References
- Acheson, N. H. (2007). Fundamentals of molecular virology. Wiley.
- Adepoju, P. (2020). Moving on from the failed HIV vaccine clinical trial. The Lancet HIV, 7(3), e161. https://doi.org/https://doi.org/10.1016/S2352-3018(20)30047-3
- Alencar, W. K., Duarte, P. S., & Waldman, E. A. (2014). Survival analysis of acquired immune deficiency syndrome patients with and without hepatitis C virus infection at a reference center for sexually transmitted diseases/acquired immune deficiency syndrome in São Paulo, Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases, 18(2), 150–157. https://doi.org/https://doi.org/10.1016/j.bjid.2013.06.006
- Avery, O. T., & Goebel, W. F. (1929). Chemo-immunological studies on conjugated carbohydrate-proteins: II. Immunological specificity of synthetic sugar-protein antigens. The Journal of Experimental Medicine, 50(4), 533–550. https://doi.org/https://doi.org/10.1084/jem.50.4.533
- Avery, O. T., & Goebel, W. F. (1931). Chemo-immunological studies on conjugated carbohydrate-proteins: V. The immunological specifity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein. The Journal of Experimental Medicine, 54(3), 437–447. https://doi.org/https://doi.org/10.1084/jem.54.3.437
- Bailey, J. R., Barnes, E., & Cox, A. L. (2019). Approaches, progress, and challenges to hepatitis C vaccine development. Gastroenterology, 156(2), 418–430. https://doi.org/https://doi.org/10.1053/j.gastro.2018.08.060
- Belshe, R. B., Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. A., Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., Deal, C. D., & Herpevac Trial for Women. (2012). Efficacy results of a trial of a herpes simplex vaccine. The New England Journal of Medicine, 366(1), 34–43. https://doi.org/https://doi.org/10.1056/NEJMoa1103151
- Berche, P. (2012). Louis Pasteur, from crystals of life to vaccination. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(Suppl 5), 1–6. https://doi.org/https://doi.org/10.1111/j.1469-0691.2012.03945.x
- Bloch, H. (1993). Edward Jenner (1749–1823). The history and effects of smallpox, inoculation, and vaccination. American Journal of Diseases of Children (1960)), 147(7), 772–774. https://doi.org/https://doi.org/10.1001/archpedi.1993.02160310074022
- Bornholdt, Z. A., Noda, T., Abelson, D. M., Halfmann, P., Wood, M. R., Kawaoka, Y., & Saphire, E. O. (2013). Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. Cell, 154(4), 763–774. https://doi.org/https://doi.org/10.1016/j.cell.2013.07.015
- Burton, D. R. (2002). Antibodies, viruses and vaccines. Nature Reviews. Immunology, 2(9), 706–713. https://doi.org/https://doi.org/10.1038/nri891
- Chan, D. P., Sun, H. Y., Wong, H. T., Lee, S. S., & Hung, C. C. (2016). Sexually acquired hepatitis C virus infection: A review. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 49, 47–58. https://doi.org/https://doi.org/10.1016/j.ijid.2016.05.030
- Chaurasiya, S., Chen, N. G., & Warner, S. G. (2018). Oncolytic virotherapy versus cancer stem cells: A review of approaches and mechanisms. Cancers ( Cancers), 10(4). 124. https://doi.org/https://doi.org/10.3390/cancers10040,
- Cheng, Y., Oldfield, C. J., Meng, J., Romero, P., Uversky, V. N., & Dunker, A. K. (2007). Mining alpha-helix-forming molecular recognition features with cross species sequence alignments. Biochemistry, 46(47), 13468–13477. https://doi.org/https://doi.org/10.1021/bi7012273
- Chernajovsky, Y., Layward, L., & Lemoine, N. (2006). Fighting cancer with oncolytic viruses. BMJ (Clinical Research ed.).), 332(7534), 170–172. https://doi.org/https://doi.org/10.1136/bmj.332.7534.170
- Du, J., Wang, X., Ma, J., Wang, J., Qin, Y., Zhu, C., Liu, F., Shao, Y., Zhou, J., Qiao, W., & Liu, X. (2014). Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain. Retrovirology, 11, 26 https://doi.org/https://doi.org/10.1186/1742-4690-11-26
- Dunham, S. P., Bruce, J., MacKay, S., Golder, M., Jarrett, O., & Neil, J. C. (2006). Limited efficacy of an inactivated feline immunodeficiency virus vaccine. The Veterinary Record, 158(16), 561–562. https://doi.org/https://doi.org/10.1136/vr.158.16.561
- Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., Oldfield, C. J., Campen, A. M., Ratliff, C. M., Hipps, K. W., Ausio, J., Nissen, M. S., Reeves, R., Kang, CHee., Kissinger, C. R., Bailey, R. W., Griswold, M. D., Chiu, W., Garner, E. C., & Obradovic, Z. (2001). Intrinsically disordered protein. Journal of Molecular Graphics and Modelling, 19(1), 26–59. https://doi.org/https://doi.org/10.1016/S1093-3263(00)00138-8
- Esparza, J. (2013). A brief history of the global effort to develop a preventive HIV vaccine. Vaccine, 31(35), 3502–3518. https://doi.org/https://doi.org/10.1016/j.vaccine.2013.05.018
- Fonseca, A. A., Jr., Heinemann, M. B., Leite, R. C., & Reis, J. K. (2010). A comparative analysis of envelope and tegument proteins of suid herpesvirus 1, bovine herpesvirus 1 and bovine herpesvirus 5. Archives of Virology, 155(10), 1687–1692. https://doi.org/https://doi.org/10.1007/s00705-010-0747-4
- Garner, E., Romero, P., Dunker, A. K., Brown, C., & Obradovic, Z. (1999). Predicting Binding Regions within Disordered Proteins. Genome Informatics. Workshop on Genome Informatics, 10, 41–50. https://www.ncbi.nlm.nih.gov/pubmed/11072341
- Girard, M., Kieny, M. P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., Muchmore, E. …. (1991). Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America, 88(2), 542–546. https://doi.org/https://doi.org/10.1073/pnas.88.2.542
- Giri, R., Kumar, D., Sharma, N., & Uversky, V. N. (2016). Intrinsically disordered side of the Zika virus proteome. Frontiers in Cellular and Infection Microbiology, 6, 144. https://doi.org/https://doi.org/10.3389/fcimb.2016.00144
- Goebel, W. F., & Avery, O. T. (1929). Chemo-immunological studies on conjugated carbohydrate-proteins : I. The synthesis of p-aminophenol beta-glucoside, p-aminophenol beta-galactoside, and their coupling with serum globulin. Journal of Experimental Medicine, 50(4), 521–531. https://doi.org/https://doi.org/10.1084/jem.50.4.521
- Goh, G. K., Dunker, A. K., Foster, J. A., & Uversky, V. N. (2019b). Zika and flavivirus shell disorder: Virulence and fetal morbidity. Biomolecules, 9(11), 710. https://doi.org/https://doi.org/10.3390/biom9110710
- Goh, G. K. (2017). Viral shapeshifters: Strange behaviors of HIV and other viruses. Simplicity Research Institute.
- Goh, G. K., Dunker, A. K., & Uversky, V. (2013). Prediction of intrinsic disorder in MERS-CoV/HCoV-EMC supports a high oral-fecal transmission. PLoS Currents Outbreaks. https://doi.org/https://doi.org/10.1371/currents.outbreaks.22254b58675cdebc256dbe3c5aa6498b
- Goh, G. K., Dunker, A. K., & Uversky, V. N. (2008a). A comparative analysis of viral matrix proteins using disorder predictors. Virology Journal, 5, 126. https://doi.org/https://doi.org/10.1186/1743-422X-5-126
- Goh, G. K., Dunker, A. K., & Uversky, V. N. (2008b). Protein intrinsic disorder toolbox for comparative analysis of viral proteins. BMC Genomics, 9(Suppl 2), S4. https://doi.org/https://doi.org/10.1186/1471-2164-9-S2-S4
- Goh, G. K., Dunker, A. K., & Uversky, V. N. (2009). Protein intrinsic disorder and influenza virulence: The 1918 H1N1 and H5N1 viruses. Virology Journal, 6, 69. https://doi.org/https://doi.org/10.1186/1743-422X-6-69
- Goh, G. K., Dunker, A. K., & Uversky, V. N. (2012). Understanding viral transmission behavior via protein intrinsic disorder prediction: Coronaviruses. Journal of Pathogens, 2012, 738590. https://doi.org/https://doi.org/10.1155/2012/738590
- Goh, G. K., Dunker, A. K., & Uversky, V. N. (2015a). Detection of links between Ebola nucleocapsid and virulence using disorder analysis. Molecular Biosystems, 11(8), 2337–2344. https://doi.org/https://doi.org/10.1039/c5mb00240k
- Goh, G. K., Dunker, A. K., & Uversky, V. N. (2015b). Shell disorder, immune evasion and transmission behaviors among human and animal retroviruses. Molecular Biosystems, 11(8), 2312–2323. https://doi.org/https://doi.org/10.1039/c5mb00277j
- Goh, G. K., Dunker, A. K., & Uversky, V. N. (2016). Correlating Flavivirus virulence and levels of intrinsic disorder in shell proteins: Protective roles vs. immune evasion. Molecular Biosystems, 12(6), 1881–1891. https://doi.org/https://doi.org/10.1039/C6MB00228E
- Goh, G. K., Dunker, A. K., Foster, J. A., & Uversky, V. N. (2019a). HIV vaccine mystery and viral shell disorder. Biomolecules, 9(5), 178. https://doi.org/https://doi.org/10.3390/biom9050178
- Goh, G. K., Dunker, A. K., Foster, J. A., & Uversky, V. N. (2020a). Nipah shell disorder, modes of infection, and virulence. Microbial Pathogenesis, 141, 103976. https://doi.org/https://doi.org/10.1016/j.micpath.2020.103976
- Goh, G. K., Dunker, A. K., Foster, J. A., & Uversky, V. N. (2020b). Rigidity of the outer shell predicted by a protein intrinsic disorder model sheds light on the COVID-19 (Wuhan-2019-nCoV) infectivity. Biomolecules, 10(2), 331. 3390/biom10020331 https://doi.org/https://doi.org/10.3390/biom10020331
- Goh, G. K., Dunker, A. K., Foster, J. A., & Uversky, V. N. (2020c). Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids. Microbial Pathogenesis, 144, 104177. https://doi.org/https://doi.org/10.1016/j.micpath.2020.104177
- Goh, G. K., Foster, J. A., Dunker, A. K., & Uversky, V. N. (2019). Nipah shell disorder, modes of infection and virulence. Microbial Pathogenesis, 141, 103976. https://doi.org/https://doi.org/10.1016/j.micpath.2020.103976
- Goudsmit, J. (1997). Viral sex: The nature of AIDS. Oxford University Press.
- Grigg, C., Blake, Z., Gartrell, R., Sacher, A., Taback, B., & Saenger, Y. (2016). Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers. Seminars in Oncology, 43(6), 638–646. https://doi.org/https://doi.org/10.1053/j.seminoncol.2016.10.005
- Guo, H., Shen, S., Wang, L., & Deng, H. (2010). Role of tegument proteins in herpesvirus assembly and egress. Protein & Cell, 1(11), 987–998. https://doi.org/https://doi.org/10.1007/s13238-010-0120-0
- John, T. J. (2004). The golden jubilee of vaccination against poliomyelitis. The Indian Journal of Medical Research, 119(1), 1–17. http://www.ncbi.nlm.nih.gov/pubmed/14997988
- Kato, A., Liu, Z., Minowa, A., Imai, T., Tanaka, M., Sugimoto, K., Nishiyama, Y., Arii, J., & Kawaguchi, Y. (2011). Herpes simplex virus 1 protein kinase Us3 and major tegument protein UL47 reciprocally regulate their subcellular localization in infected cells. Journal of Virology, 85(18), 9599–9613. https://doi.org/https://doi.org/10.1128/JVI.00845-11
- Keen, E. C. (2015). A century of phage research: Bacteriophages and the shaping of modern biology. BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology, 37(1), 6–9. https://doi.org/https://doi.org/10.1002/bies.201400152
- Koelle, D. M., Norberg, P., Fitzgibbon, M. P., Russell, R. M., Greninger, A. L., Huang, M.-L., Stensland, L., Jing, L., Magaret, A. S., Diem, K., Selke, S., Xie, H., Celum, C., Lingappa, J. R., Jerome, K. R., Wald, A., & Johnston, C. (2017). Worldwide circulation of HSV-2 × HSV-1 recombinant strains. Scientific Reports, 7, 44084. https://doi.org/https://doi.org/10.1038/srep44084
- Lambers, F. A. E., Prins, M., Thomas, X., Molenkamp, R., Kwa, D., Brinkman, K., van der Meer, J. T. M., Schinkel, J., & MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group. (2011). Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS (London, England)), 25(17), F21–27. https://doi.org/https://doi.org/10.1097/QAD.0b013e32834bac44
- Lemey, P., Pybus, O. G., Wang, B., Saksena, N. K., Salemi, M., & Vandamme, A. M. (2003). Tracing the origin and history of the HIV-2 epidemic. Proceedings of the National Academy of Sciences of the United States of America, 100(11), 6588–6592. https://doi.org/https://doi.org/10.1073/pnas.0936469100
- Leroux, C., Cadore, J. L., & Montelaro, R. C. (2004). Equine Infectious Anemia Virus (EIAV): What has HIV's country cousin got to tell us? Veterinary Research, 35(4), 485–512. https://doi.org/https://doi.org/10.1051/vetres:2004020
- Levine, A. J. (1991). Viruses. Henry Holt and Co.
- Li, F., Craigo, J. K., Howe, L., Steckbeck, J. D., Cook, S., Issel, C., & Montelaro, R. C. (2003). A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. Journal of Virology, 77(13), 7244–7253. https://doi.org/https://doi.org/10.1128/jvi.77.13.7244-7253.2003
- Malamud, D., Abrams, W. R., Barber, C. A., Weissman, D., Rehtanz, M., & Golub, E. (2011). Antiviral activities in human saliva. Advances in Dental Research, 23(1), 34–37. https://doi.org/https://doi.org/10.1177/0022034511399282
- Malmquist, W. A., Barnett, D., & Becvar, C. S. (1973). Production of equine infectious anemia antigen in a persistently infected cell line. Archiv Fur Die Gesamte Virusforschung, 42(4), 361–370. https://doi.org/https://doi.org/10.1007/BF01250717
- Miller, C., Emanuelli, M., Fink, E., Musselman, E., Mackie, R., Troyer, R., Elder, J., & VandeWoude, S. (2018). FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge. NPJ Vaccines, 3, 16. https://doi.org/https://doi.org/10.1038/s41541-018-0051-y
- Moelling, K. (2015). Viruses: More friends than foes. World Scientific.
- Montelaro, R. C., Grund, C., Raabe, M., Woodson, B., Cook, R. F., Cook, S., & Issel, C. J. (1996). Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines. AIDS Res Hum Retroviruses, 12(5), 413–415. https://doi.org/https://doi.org/10.1089/aid.1996.12.413
- Moor-Jankowski, J. (1991). The first successful AIDS vaccine: Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Journal of Medical Primatology, 20(1), 47–48. http://www.ncbi.nlm.nih.gov/pubmed/2051469
- Nieuwenhuis, R. F., van Doornum, G. J., Mulder, P. G., Neumann, H. A., & van der Meijden, W. I. (2006). Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes. Acta Derm Venereol, 86(2), 129–134. https://doi.org/https://doi.org/10.2340/00015555-0029
- Norrby, E. (2007). Yellow fever and Max Theiler: The only Nobel Prize for a virus vaccine. The Journal of Experimental Medicine, 204(12), 2779–2784. https://doi.org/https://doi.org/10.1084/jem.20072290
- Oldfield, C. J., Cheng, Y., Cortese, M. S., Romero, P., Uversky, V. N., & Dunker, A. K. (2005). Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry, 44(37), 12454–12470. https://doi.org/https://doi.org/10.1021/bi050736e
- Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012). Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. The Lancet. Infectious Diseases, 12(1), 36–44. https://doi.org/https://doi.org/10.1016/S1473-3099(11)70295-X
- Riedel, S. (2005). Edward Jenner and the history of smallpox and vaccination. Proceedings (Baylor University. Medical Center)), 18(1), 21–25. https://doi.org/https://doi.org/10.1080/08998280.2005.11928028
- Romero, P., Obradovic, Z., Kissinger, C., Villafranca, J. E., & A. K, D. (1997, June 12). Identifying disordered regions in proteins from amino acid sequence [Paper presentation]. Paper Presented at the IEEE International Conference on Neural Networks, Houston, TX.
- Sahay, B., & Yamamoto, J. K. (2018). Lessons learned in developing a commercial FIV vaccine: The immunity required for an effective HIV-1 vaccine. Viruses, 10(5), 277. https://doi.org/https://doi.org/10.3390/v10050277
- Scherk, M. A., Ford, R. B., Gaskell, R. M., Hartmann, K., Hurley, K. F., Lappin, M. R., Levy, J. K., Little, S. E., Nordone, S. K., & Sparkes, A. H. (2013). 2013 AAFP feline vaccination advisory panel report. Journal of Feline Medicine and Surgery, 15(9), 785–808. https://doi.org/https://doi.org/10.1177/1098612X13500429
- Tagmyer, T. L., Craigo, J. K., Cook, S. J., Even, D. L., Issel, C. J., & Montelaro, R. C. (2008). Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition. Journal of Virology, 82(8), 4052–4063. https://doi.org/https://doi.org/10.1128/JVI.02028-07
- Tompa, P. (2002). Intrinsically unstructured proteins. Trends in Biochemical Sciences, 27(10), 527–533. https://doi.org/https://doi.org/10.1016/S0968-0004(02)02169-2
- Trigo, G., Martins, T. G., Fraga, A. G., Longatto-Filho, A., Castro, A. G., Azeredo, J., & Pedrosa, J. (2013). Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model. PLoS Neglected Tropical Diseases, 7(4), e2183. https://doi.org/https://doi.org/10.1371/journal.pntd.0002183
- Uversky, V. N., Gillespie, J. R., & Fink, A. L. (2000). Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins: Structure, Function, and Genetics, 41(3), 415–427. https://www.ncbi.nlm.nih.gov/pubmed/11025552
- Vigerust, D. J., & Shepherd, V. L. (2007). Virus glycosylation: Role in virulence and immune interactions. Trends in Microbiology, 15(5), 211–218. https://doi.org/https://doi.org/10.1016/j.tim.2007.03.003
- Wang, H. N., Rao, D., Fu, X. Q., Hu, M. M., & Dong, J. G. (2018). Equine infectious anemia virus in China. Oncotarget, 9(1), 1356–1364. https://doi.org/https://doi.org/10.18632/oncotarget.20381
- Wang, X.-F., Lin, Y.-Z., Li, Q., Liu, Q., Zhao, W.-W., Du, C., Chen, J., Wang, X., & Zhou, J.-H. (2016). Genetic evolution during the development of an attenuated EIAV vaccine. Retrovirology, 13, 9. https://doi.org/https://doi.org/10.1186/s12977-016-0240-6
- Wei, D., Xu, J., Liu, X. Y., Chen, Z. N., & Bian, H. (2018). Fighting cancer with viruses: Oncolytic virus therapy in China. Human Gene Therapy, 29(2), 151–159. https://doi.org/https://doi.org/10.1089/hum.2017.212
- Wright, P. E., & Dyson, H. J. (1999). Intrinsically unstructured proteins: Re-assessing the protein structure-function paradigm. Journal of Molecular Biology, 293(2), 321–331. https://doi.org/https://doi.org/10.1006/jmbi.1999.3110
- Xue, B., Williams, R. W., Oldfield, C. J., Goh, G. K., Dunker, A. K., & Uversky, V. N. (2010). Viral disorder or disordered viruses: Do viral proteins possess unique features? Protein and Peptide Letters, 17(8), 932–951. https://doi.org/https://doi.org/10.2174/092986610791498984